BISU<<<Bio-Solutions++_mons$ter_DD_Corporation Completes Initial Production of Diabetic Product, Type2 Defense
((runner in preparation!!!!!
2013-06-27 08:45 ET - News Release
SAN ANTONIO, TEXAS -- (Marketwired) -- 06/27/13
Bio-Solutions Corporation (OTCBB:BISU)(PINKSHEETS:BISU) is pleased to announce that the company has completed its initial order of the diabetic product Type2 Defense with Nutricap Labs located in Farmingdale, New York. The successful completion of the initial production order is an important milestone for Bio-Solutions Corporation. The company is now positioned to distribute final product samples to the different groups that are presently considering endorsing the Type2 Defense product and begin set-up of proper distribution channels for the product.
Type2 Defense is a preventative supplement for people who are diabetic or who are pre-diabetic. The product helps regulate blood sugar and blood pressure levels in diabetic and pre-diabetic subjects, especially for those who are insulin-resistant. "The company recognizes the diabetic epidemic that is happening in this country and throughout the world. We are excited to now be able to offer such a dynamic nutritional supplement that supports healthy living in the diabetic community" says CEO Bill Gallagher.
Contacts:
William Gallagher
Chief Executive Officer
Bio-Solutions Corporation
210-218-4475
info@biosolutionscorp.com
((((Top line revenue should explode as we roll out professional athlete endorsements for the product by players in the NHL, NFL, NBA and MLB. )))) $$ news to follow..
BISU recent filng 10-Q ++More..DD..must>>>read May 6, 2013 Mar 31, 2013
http://www.otcmarkets.com/stock/BISU/filings
http://www.stockwatch.com/News/Item.aspx?bid=U-i875030001-U%3aBISU-20130520&symbol=BISU®ion=U
Chicago Bears Quarterback Jay Cutler in Talks With Bio-Solutions Corp-UPDATE
2013-05-20 13:02 ET - News Release
CHICAGO, ILLINOIS -- (Marketwired) -- 05/20/13
Bio-Solutions Corporation (OTCBB:BISU)(PINKSHEETS:BISU) is announcing today that Chicago Bears quarterback Jay Cutler is currently looking over an endorsement deal involving their diabetic product, Type-2 Defense, which is a preventative supplement for people who are diabetic or who are pre-diabetic. This product helps regulate blood sugar and blood pressure levels in diabetic and pre-diabetic subjects, especially for those who are insulin-resistant.
Bio-Solutions and Mark Block, who is head of the Jay Cutler Foundation, have been involved in preliminary talks concerning the endorsement deal for the past 4 weeks with outside consultants who were brought in by Bio-Solutions. They brought in outside consultants whose sole purpose was to find the best suitable athletes to endorse their Type-2 Defense product and carry their company's mission while representing their vision.
Bio-Solutions recognizes Jay Cutler as the best possible candidate because of his long-term battle with type-1 diabetes and his generosity in helping others who suffer from diabetes. Cutler, who established the Jay Cutler Foundation, raises money for diabetes research and to help children with type-1 diabetes.
Type-2 Defense samples are in the process of being shipped to Mark Block in Nashville, Tennessee where after received they will contact the National Football League to confirm that all the ingredients are compatible with the National Football Leagues' collective bargaining agreement. Bio-Solutions' Type-2 Defense samples should arrive to Block Agency in Nashville at the end of this week.
Jay Cutler will be looking over the Type-2 Defense product and the proposed endorsement deal over the next week and will make a decision on whether or not to take on this endorsement deal and team up with Bio-Solutions Corporation.
Contacts:
Josh Williams
Endorsement Deal Coordinator
Cell Phone: 312-636-1471
joshwilliams0626@yahoo.com
by : Josh Williams
NFL Analyst
Fox Sports Radio - 95.7 The Fan
joshwilliams0626@yahoo.com
1-312-636-1471
http://www.stockwatch.com/News/Item.aspx?bid=U-i874782001-U%3aBISU-20130520&symbol=BISU®ion=U
Product on line soon!! For JULY!!!!!!!
Bio-Solutions Corp. has launched the new product - Type2 Defense™ - to tap into the rapidly growing demand for diabetic and functional supplementation. Type2 Defense™ will soon be sold on the company’s website www.type2defense.com (currently under development).
BISU partner
www.nutricaplabs.com/ ( fortune500 ) agreement$$
BISU_Dana Vice President of the UK’s_Naturopathic_Nutrition Association (NMA).
HIGHLY REGARDED NATUROPATH_TO JOIN BIO-SOLUTIONS
Bio-Solutions Corp is pleased to announce the addition of Ms. Dana Kraft as a team member. Ms. Kraft is a UK-trained Naturopath, specialist in Nutritional Therapy, Herbal Medicine and Flower Essence Therapy.
Upon completing her Masters dissertation in Media and Alternative Medicine at Goldsmiths College, University of London in 2005, Ms. Kraft realized that her real passion lay in natural medicine. Dana earned her diplomas at the prestigious College of Naturopathic Medicine (CNM) in London, graduating with qualifications in Nutritional Therapy, Herbal Medicine and Naturopathy. Dana also holds a BA in Communications from Tulane University and is co-founder and former Vice President of the UK’s Naturopathic Nutrition Association (NMA).
Philosophy and Approach
The European style of naturopathy is an ‘eclectic’ approach to healing. Various tools and perspectives are incorporated in order to help set each individual on the right healing path. Herbal remedies, nutrition advice, flower essences, lifestyle changes and more will be recommended to clients as deemed appropriate for the individual. Dana often uses Traditional Chinese Medicine and/or Ayurvedic theory and diagnostic techniques (tongue and pulse analysis, face reading, etc.) as well as the use of Iridology, the study of the iris of the eye, to ascertain constitutional weakness and confirm suspected areas of disease in the body.
All of Dana’s work is guided by the fundamental principles of naturopathy:
The WHOLE person is treated – physically, mentally, emotionally and spiritually.
The PERSON is treated, not the disease, and each individual is unique and responds in a different way to different remedies.
The root (underlying) cause of dysfunction is identified and treated, not the branches (symptoms).
Vis Medicatrix Naturae – The healing power of nature. There is ‘vital force’ or ‘life force’ which given the right conditions, will self-heal or self-correct.
Health is much greater than just ‘absence of infirmity’ – it should be abundant vitality.
Prevention is preferable to cure.
Bio-Solutions Corp would like to welcome Ms. Kraft to our organization and look forward to working with her in the development of future products/ brands.
Bio-Solutions Corp, Owns and Markets Type2 Defense(TM) (the “Product” or the “Supplement”) is a glucose control dietary supplement powder formulated to support healthy glucose levels in addition to maintaining healthy blood pressure. Packaged with 30 packets to a box, the product powder drink mix delivery system has been developed to help support healthy glucose levels for type 2 diabetics and pre-diabetics. The product is also effective in controlling hypertension and has strong antioxidant powers.
HOW TO JACK UP YOUR PROFITS OF MCDONALDS CORP..*BISU* doesn’t like what is going on at MCD but we plan to be there when people need us. Keep an eye on your diet and your investment portfolio.
McDonalds Corp is a staple. Everyone knows McDonalds. There are McDonalds on every street corner, or so it seems. Kids grow up loving McDonalds and the Golden Arches show up as sponsors of athletic and charitable events. Ronald McDonald is part of American culture and we as a society are paying the ultimate price. The corporation known for cheap food has suffered in the court of public opinion with the release of the Super Size Me documentary. This 2004 film by Morgan Spurlock examined the effects of eating McDonalds food for 30 straight days. The results were an eye opener for America but unfortunately the steady McDonalds diet is fact not fiction for large parts of many American ghettos. In some parts of cities like LA; you have no choice but to dine on McDonalds every night because grocery stores can’t open and expect to make a profit. Families in those areas are to broke, busy (with two jobs) or transient to shop in regular markets. In those areas, McDonalds is the fast and quick solution to everything when to comes to nutrition.
This diet disaster is helping to fuel the diabetes epidemic sweeping across the US. Investors in McDonalds are making a killing as people are getting fatter and sicker. This trend might be about to turn the corner. Jumba Juice and Chipotle Mexican Grill have recognized that consumers went healthier choices and McDonalds is trying to play catch up. There healthy options are now available but the fact remains that the cheaper traditional calories laden choices will remain favorites. It is now our place to pass judgement on McDonalds. They are free to run their company in any manner they see fit. We can however recognize the opportunity by telling investors that they could both hedge and profit from existing McDonalds (MCD) investments. The obvious way to benefit from more sales out of McDonalds is to invest in companies in the diabetes space. The bigger the pool of unhealthy people, the more profit there is to be had for companies in the diabetes space.
BISU doesn’t like what is going on at MCD but we plan to be there when people need us. Keep an eye on your diet and your investment portfolio. We want you to be wealthy but we also want you to be healthy. We welcome any question you have on our product and company. Please do not hesitate to email us on the information portion on the website.
Related articles
http://www.biosolutionscorp.com/blog/how-to-jack-up-your-profits-of-mcdonalds-corp/
http://www.biosolutionscorp.com/
Diabates Demographics - Diabetes will become a bigger and bigger isssue.
THE DEMOGRAPHICS OF DIABETES ATTRACTS INVESTORS TO THE NYSE, OTCBB, AND THE TSXV
http://www.biosolutionscorp.com/blog/the-demographics-of-diabetes-attracts-investors-to-the-nyse-otcbb-and-the-tsxv/
Total prevalence of diabetes
Total: 25.8 million children and adults in the United States—8.3% of the population—have diabetes.
Diagnosed: 18.8 million people
Undiagnosed: 7.0 million people
Prediabetes: 79 million people*
New Cases: 1.9 million new cases of diabetes are diagnosed in people aged 20 years and older in 2010.
* In contrast to the 2007 National Diabetes Fact Sheet, which used fasting glucose data to estimate undiagnosed diabetes and prediabetes, the 2011 National Diabetes Fact Sheet uses both fasting glucose and A1C levels to derive estimates for undiagnosed diabetes and prediabetes. These tests were chosen because they are most frequently used in clinical practice.
Under 20 years of age
215,000, or 0.26% of all people in this age group have diabetes
About 1 in every 400 children and adolescents has diabetes
Age 20 years or older
25.6 million, or 11.3% of all people in this age group have diabetes
Age 65 years or older
10.9 million, or 26.9% of all people in this age group have diabetes
Men
13.0 million, or 11.8% of all men aged 20 years or older have diabetes
Women
12.6 million, or 10.8% of all women aged 20 years or older have diabetes
Race and ethnic differences in prevalence of diagnosed diabetes
After adjusting for population age differences, 2007-2009 national survey data for people diagnosed with diabetes, aged 20 years or older include the following prevalence by race/ethnicity:
7.1% of non-Hispanic whites
8.4% of Asian Americans
12.6% of non-Hispanic blacks
11.8% of Hispanics
Among Hispanics rates were:
7.6% for Cubans
13.3% for Mexican Americans
13.8% for Puerto Ricans.
Morbidity and Mortality
In 2007, diabetes was listed as the underlying cause on 71,382 death certificates and was listed as a contributing factor on an additional 160,022 death certificates. This means that diabetes contributed to a total of 231,404 deaths.
Complications
Heart disease and stroke
In 2004, heart disease was noted on 68% of diabetes-related death certificates among people aged 65 years or older.
In 2004, stroke was noted on 16% of diabetes-related death certificates among people aged 65 years or older.
Adults with diabetes have heart disease death rates about 2 to 4 times higher than adults without diabetes.
The risk for stroke is 2 to 4 times higher among people with diabetes.
High blood pressure
In 2005-2008, of adults aged 20 years or older with self-reported diabetes, 67% had blood pressure greater than or equal to 140/90 mmHg or used prescription medications for hypertension.
Blindness
Diabetes is the leading cause of new cases of blindness among adults aged 20–74 years.
In 2005-2008, 4.2 million (28.5%) people with diabetes aged 40 years or older had diabetic retinopathy, and of these, almost 0.7 million (4.4% of those with diabetes) had advanced diabetic retinopathy that could lead to severe vision loss.
Kidney disease
Diabetes is the leading cause of kidney failure, accounting for 44% of new cases in 2008.
In 2008, 48,374 people with diabetes began treatment for end-stage kidney disease in the United States.
In 2008, a total of 202,290 people with end-stage kidney disease due to diabetes were living on chronic dialysis or with a kidney transplant in the United States.
Nervous system disease (Neuropathy)
About 60% to 70% of people with diabetes have mild to severe forms of nervous system damage.
Amputation
More than 60% of nontraumatic lower-limb amputations occur in people with diabetes.
In 2006, about 65,700 nontraumatic lower-limb amputations were performed in people with diabetes.
Cost of Diabetes
Updated March 6, 2013
$245 billion: Total costs of diagnosed diabetes in the United States in 2012
$176 billion for direct medical costs
$69 billion in reduced productivity
After adjusting for population age and sex differences, average medical expenditures among people with diagnosed diabetes were 2.3 times higher than what expenditures would be in the absence of diabetes.
Read more about the results of our study "Economic Costs of Diabetes in the U.S. in 2012.”
For Additional Information
These statistics and additional information can be found in the National Diabetes Fact Sheet, 2011, the most recent comprehensive assessment of the impact of diabetes in the United States, jointly produced by the CDC, NIH, ADA, and other organizations.
You can download the Association's two-page summary in PDF format from DiabetesPro.
Want to Do Something About It?
Don't like these numbers? We don't either.
Join the Millions? in the fight to Stop Diabetes®!
Make a donation to the American Diabetes Association to help fund leading-edge research that affects the health and well-being of millions of people living with diabetes. Your funds are put to work immediately to support important research efforts and help provide much needed services to people with diabetes.
@@@Diabetes cases to grow to 29 million in 2050 in the US @@@@
NATURAL REMEDIES LIKE MEDICAL MARIJUANA CAN IMPACT DIABETES
http://www.biosolutionscorp.com/blog/natural-remedies-like-medical-marijuana-can-impact-diabetes/
BISU value for 2013-2014 0.30-0.50 Under 0.10 big buyers coming
>>>>>>Type 2 Diabetes Set to Explode in the US <<<<<
BISU IN A MULTI BILLION-DOLLAR_MARKET-AND_LOOKING_AT ANOTHER
http://www.biosolutionscorp.com/blog/bisu-in-a-multi-billion-dollar-market-and-looking-at-another/
BISU.MEDICAL MARIJUANA COULD BE THE_PATH_TO_WELLNESS_AND_PROSPERITY
http://www.biosolutionscorp.com/blog/medical-marijuana-could-be-the-path-to-wellness-and-prosperity/
MEDICAL MARIJUANA COULD BE THE PATH TO WELLNESS AND PROSPERITY
Our company entered the natural remedy field with our initial product offering to help diabetes patients deal with their condition. We have big plans for the roll out including endorsement deals with NFL and NHL athletes. These endorsement deals are in the advanced discussion stage and we anticipate being in a position to release news on these undertakings before month end. This product is at the core of our company’s mission to build our reputation as a Natural Remedy Company.
Searching for new opportunities is a lynchpin to our growth strategy. We have ben watching the whole medical marijuana debate with keen interest. Our group is interested in the sector because of the natural remedy component.
http://www.bottomlinepublications.com/content/article/natural-remedies/medical-marijuana
The addition of a medical marijuana project to our product portfolio could propel growth and put the company in an enviable position by being immediately accretive. A series of projects are under consideration and we will release news as soon as a final decision is made by management. This is an important decision given the potential positive impact in terms of building value for our shareholders. Companies like Medbox Inc. (http://www.thedispensingsolution.com/) and Medical Marijuana Inc. (http://www.medicalmarijuanainc.com/) have been trailblazers in the space and in the process they have created enormous wealth for investors. We think we could do the same by chosing the right project.
BISU THIS YEAR WILL BE A LANDMARK YEAR FOR_TYPE 2 DEFENSE
http://www.biosolutionscorp.com/blog/this-year-will-be-a-landmark-year-for-type-2-defense/
THIS YEAR WILL BE A LANDMARK YEAR FOR TYPE 2 DEFENSE
We are very excited to enter this new year with high hopes and expectations. The company has gone through intensive periods of startegic planning and we are confident that we are well positioned to deliver on the core product line for Bio-Solutions Corp. As shareholders know, we are preparing to market Type 2 Defense and it is our belief that the marketplace will be very receptive to the the superior formulation of this unique product in the diabetes space.
Americans are suffering from diabetes in growing numbers, The demographics point to a 100% + increase in cases to almost 30 million by 2050. This huge jump in cases bodes well for our product and the sales should reflect that this year and in years to come. Our expectation for Type 2 Defense are very high and the management team will be working hard to make sure that shareholders share in the rewards of a product has all the earmarks of a winner.
Bio-Solutions plans for Type 2 Defense include athlete endorsements, regional and countrywide distribution and media events (US and Canada). Our time is now and we are confident that we will take the opportunity to have a solid product launch and follow through. Management has established relationships with outside marketing help that has successfully marketed these type of products in the past. This will be a very interesting time to be a shareholder. We will work hard to deliver value and results and turn the share price around to more normalized levels. If you have any questions, please do not hesitate to contact us.
Related articles
BISU PROFITS AND DEALS ((NHL-NFL-MLB..endorsement..to follow..
We have been hard at work for the past four weeks and it looks like we are about ready to make our big move. Our Type 2 Defense product is in full production mode and the roll out is set to begin early next month. This diabetes product has a huge market and healthy margins. We intend to have an aggressive online marketing campaign with this product as the focal point. The sales effort will be anchored by endorsements from some of the professional athletes we are talking with at this time. Having the endorsement of MLB, NFL and NHL: players will create organic visibility for the product launch. The generous margins for Type 2 Defense will allow the company to become cash flow positive very quickly. A successful Type 2 Defense launch will be a template for other products in our pipeline.
Our shareholders can also expect to see some acquisition news, shortly. The company has been investigating many natural remedy opportunities including some in the medical marijuana space. The medical marijuana opportunities offered to the company have significant upside so makinga decision is not a simple as it would seem. The variety of these projects has led to a longer than expected due diligence period but we are winding this process down and we think we will be a in a position to make an announcement very soon. Management is focused on insuring that the new opportunities are in sync with the focus on natural remedies and have the same margin profile as our primary product.
RELATED POSTS
http://www.biosolutionscorp.com/blog/bisu-in-a-multi-billion-dollar-market-and-looking-at-another/
BISU .. NFL johnson is sensitive to the_cause_of_diabetes.read
http://bleacherreport.com/articles/1598137-nico-johnson-scouting-report-nfl-outlook-for-alabama-ilb
http://www.biosolutionscorp.com/blog/nico-johnson-scouting-report-nfl-outlook-for-alabama-ilb/
http://www.biosolutionscorp.com/blog/meet-kendall-simmons/
http://www.dlife.com/diabetes/famous_people/sports/jay-cutler-biography
Our team will be solidly implanted in that market with Type 2 Defense and the other products in development. Top line revenue should explode as we roll out professional athlete endorsements for the product by players in the NHL, NFL, NBA and MLB.
BISU invites shareholders_$HEMP_$MJNA_$MDBX_$CLNP_$SKTO_$FITX_to consider our company and visit our website
BISU Diabetes Stocks - The perfect place to make money.
HIGH MERCURY LEVELS INCREASE_DIABETES_RISK_BY_65%
Washington: Young adults who consume high levels of mercury increase their risks for type 2 diabetes later in life by 65 percent, a new study has found. The study, led by Indiana University School of Public Health-Bloomington epidemiologist Ka He …
http://zeenews.india.com/news/health/healthy-eating/high-mercury-levels-increase-diabetes-risk-by-65_21336.html
SOLUTION = BISU product http://www.biosolutionscorp.com/products/
Nutrition May Affect Quality of Life in People with Diabetes
http://www.biosolutionscorp.com/blog/nutrition-may-affect-quality-of-life-in-people-with-diabetes
News 
Market Data 
Discover 
AI
